| Sign In to gain access to subscriptions and/or personal tools. |
Obsessive-compulsive disorder in UK clozapine-treated schizophrenia and schizoaffective disorder: a cause for clinical concern
1 National Obsessive Compulsive Disorders Treatment Service, Department
of Psychiatry, Queen Elizabeth II Hospital, Herts. Partnership NHS Foundation
Trust, Welwyn Garden City, Hertfordshire, UK
* To whom correspondence should be addressed.
Abstract The association between schizophrenia and obsessive-compulsive disorder (OCD) is complex. This study systematically examined a UK cohort of clozapine-treated individuals with schizophrenia/schizoaffective disorder. Fourteen of 59 cases (24%) scored positively on item H of the Mini-International Neuropsychiatric Interview (MINI) for OCD. The mean Yale–Brown Obsessive-Compulsive Scale (Y-BOCS) score in MINI-positive cases was 17.6 (SD ± 6.3). Sixty-four percent scored 16 or more on the Y-BOCS, representing clinically meaningful illness severity. Seven (50%) patients with OCD had previously received the diagnosis by their treating clinicians and were already receiving with selective serotonin re-uptake inhibitors (SSRIs) treatment. OCD cases scored significantly worse than their non-OCD counterparts on the Abnormal Involuntary Movement Scale (P = 0.01) and the Simpson Angus Scale (SAS; P ratings for OCD cases on the Clinical Global Impression-Schizophrenia scale (P n not on SSRI (n (P clozapine for schizophrenic disorders and that the comorbidity is associated with greater motoric impairment. The role of medication in this condition remains unclear. Key Words: clozapine, OCD, schizophrenia
First published on May 30, 2008, doi:10.1177/0269881108089582 |
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||